Phenotypic differences between Drosophila Alzheimer’s disease models expressing human Aβ42 in the developing eye and brain

References

• Ambegaokar SS, Jackson GR. 2011. Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum Mol Genet. 20:4947–4977. doi: 10.1093/hmg/ddr432
   PubMed Web of Science ®Google Scholar
• Ando K, Maruko-Otake A, Ohtake Y, Hayashishita M, Sekiya M, Iijima KM. 2016. Stabilization of microtubule-unbound Tau via Tau phosphorylation at Ser262/356 by Par-1/MARK contributes to augmentation of AD-related phosphorylation and Aβ42-induced Tau toxicity. PLoS Genet. 12:e1005917. doi: 10.1371/journal.pgen.1005917
   PubMed Web of Science ®Google Scholar
• Bang SM, Lee S, Jeong H, Hong YK, Lee JH, Hwang S, Suh YS, Lee K, Cho KS. 2016. Effects of sarah/nebula knockdown on Aβ42-induced phenotypes during Drosophila development. Genes Genomics. 38:479–487. doi: 10.1007/s13258-016-0407-5
   Web of Science ®Google Scholar
• Berridge MJ. 2010. Calcium hypothesis of Alzheimer’s disease. Pflugers Arch. 459:441–449. doi: 10.1007/s00424-009-0736-1
   PubMed Web of Science ®Google Scholar
• Cao W, Song HJ, Gangi T, Kelkar A, Antani I, Garza D, Konsolaki M. 2008. Identification of novel genes that modify phenotypes induced by Alzheimer’s β-amyloid overexpression in Drosophila. Genetics. 178:1457–1471. doi: 10.1534/genetics.107.078394
   PubMed Web of Science ®Google Scholar
• Caricasole A, Copani A, Caruso A, Caraci F, Iacovelli L, Sortino MA, Terstappen GC, Nicoletti F. 2003. The Wnt pathway, cell-cycle activation and β-amyloid: novel therapeutic strategies in Alzheimer’s disease? Trends Pharmacol Sci. 24:233–238. doi: 10.1016/S0165-6147(03)00100-7
   PubMed Web of Science ®Google Scholar
• Casas-Tinto S, Zhang Y, Sanchez-Garcia J, Gomez-Velazquez M, Rincon-Limas DE, Fernandez-Funez P. 2011. The ER stress factor XBP1s prevents amyloid-β neurotoxicity. Hum Mol Genet. 20:2144–2160. doi: 10.1093/hmg/ddr100
   PubMed Web of Science ®Google Scholar
• Chiang HC, Iijima K, Hakker I, Zhong Y. 2009. Distinctive roles of different β-amyloid 42 aggregates in modulation of synaptic functions. FASEB J. 23:1969–1977. doi: 10.1096/fj.08-121152
   PubMed Web of Science ®Google Scholar
• Chiang HC, Wang L, Xie Z, Yau A, Zhong Y. 2010. PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila. Proc Natl Acad Sci U S A. 107:7060–7065. doi: 10.1073/pnas.0909314107
   PubMed Web of Science ®Google Scholar
• Chouhan AK, Guo C, Hsieh YC, Ye H, Senturk M, Zuo Z, Li Y, Chatterjee S, Botas J, Jackson GR, et al. 2016. Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease. Acta Neuropathol Commun. 4:62. doi: 10.1186/s40478-016-0333-4
   PubMed Web of Science ®Google Scholar
• Du Yan S, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, et al. 1996. RAGE and amyloid-β peptide neurotoxicity in Alzheimer’s disease. Nature. 382:685–691. doi: 10.1038/382685a0
   PubMed Web of Science ®Google Scholar
• Ebenezer PJ, Weidner AM, LeVine H, Markesbery WR, Murphy MP, Zhang L, Dasuri K, Fernandez-Kim SO, Bruce-Keller AJ, Gavilan E, et al. 2010. Neuron specific toxicity of oligomeric amyloid-beta: role for JUN-kinase and oxidative stress. J Alzheimers Dis. 22:839–848. doi: 10.3233/JAD-2010-101161
   PubMed Web of Science ®Google Scholar
• Fernandez-Funez P, Zhang Y, Sanchez-Garcia J, de Mena L, Khare S, Golde TE, Levites Y, Rincon-Limas DE. 2015. Anti-Aβ single-chain variable fragment antibodies exert synergistic neuroprotective activities in Drosophila models of Alzheimer’s disease. Hum Mol Genet. 24:6093–6105. doi: 10.1093/hmg/ddv321
   PubMed Web of Science ®Google Scholar
• Finelli A, Kelkar A, Song H-J, Yang H, Konsolaki M. 2004. A model for studying Alzheimer’s Aβ42-induced toxicity in Drosophila melanogaster. Mol Cell Neurosci. 26:365–375. doi: 10.1016/j.mcn.2004.03.001
   PubMed Web of Science ®Google Scholar
• Francis PT, Palmer AM, Snape M, Wilcock GK. 1999. The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatr. 66:137–147. doi: 10.1136/jnnp.66.2.137
   PubMed Web of Science ®Google Scholar
• Gerstner JR, Lenz O, Vanderheyden WM, Chan MT, Pfeiffenberger C, Pack AI. 2016. Amyloid-β induces sleep fragmentation that is rescued by fatty acid binding proteins in Drosophila. J Neurosci Res. [Epub ahead of print] doi:10.1002/jnr.23778.
   PubMedGoogle Scholar
• Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 297:353–356. doi: 10.1126/science.1072994
   PubMed Web of Science ®Google Scholar
• Hardy JA, Higgins GA. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:184–185. doi: 10.1126/science.1566067
   PubMed Web of Science ®Google Scholar
• Hong YK, Lee S, Park SH, Lee JH, Han SY, Kim ST, Kim Y-K, Jeon S, Koo B-S, Cho KS. 2012. Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer’s disease model. Biochem Biophys Res Commun. 419:49–53. doi: 10.1016/j.bbrc.2012.01.122
   PubMed Web of Science ®Google Scholar
• Hwang S, Song S, Hong YK, Choi G, Suh YS, Han SY, Lee M, Park SH, Lee JH, Lee S, et al. 2013. Drosophila DJ-1 decreases neural sensitivity to stress by negatively regulating Daxx-like protein through dFOXO. PLoS Genet. 9:e1003412. doi: 10.1371/journal.pgen.1003412
   PubMed Web of Science ®Google Scholar
• Iijima-Ando K, Hearn SA, Granger L, Shenton C, Gatt A, Chiang H-C, Hakker I, Zhong Y, Iijima K. 2008. Overexpression of neprilysin reduces Alzheimer amyloid-β42 (Aβ42)-induced neuron loss and intraneuronal Aβ42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila. J Biol Chem. 283:19066–19076. doi: 10.1074/jbc.M710509200
   PubMed Web of Science ®Google Scholar
• Iijima K, Chiang H-C, Hearn SA, Hakker I, Gatt A, Shenton C, Granger L, Leung A, Iijima-Ando K, Zhong Y. 2008. Aβ42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PloS One. 3:e1703. doi: 10.1371/journal.pone.0001703
   PubMed Web of Science ®Google Scholar
• Iijima K, Gatt A, Iijima-Ando K. 2010. Tau Ser262 phosphorylation is critical for Aβ42-induced tau toxicity in a transgenic Drosophila model of Alzheimer’s disease. Hum Mol Genet. 19:2947–2957. doi: 10.1093/hmg/ddq200
   PubMed Web of Science ®Google Scholar
• Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y. 2004. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer’s disease. Proc Natl Acad Sci U S A. 101:6623–6628. doi: 10.1073/pnas.0400895101
   PubMed Web of Science ®Google Scholar
• Jeong H, Han SY, Lee M, Lee S, Shin M, Jeon Y, Lee K, Cho KS. 2015. Roles of Tsp66E and Tsp74F in border cell migration and the maintenance of border cell adhesion in Drosophila. Genes Genomics. 37:559–565. doi: 10.1007/s13258-015-0285-2
   Web of Science ®Google Scholar
• Lang M, Fan Q, Wang L, Zheng Y, Xiao G, Wang X, Wang W, Zhong Y, B Z. 2013. Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Abeta42-induced Alzheimer’s disease-like symptoms. Neurobiol Aging. 34:2604–2612. doi: 10.1016/j.neurobiolaging.2013.05.029
   PubMed Web of Science ®Google Scholar
• Lang M, Wang L, Fan Q, Xiao G, Wang X, Zhong Y, Zhou B. 2012. Genetic inhibition of solute-linked carrier 39 family transporter 1 ameliorates aβ pathology in a Drosophila model of Alzheimer’s disease. PLoS Genet. 8:e1002683. doi: 10.1371/journal.pgen.1002683
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. 2009. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature. 457:1128–1132. doi: 10.1038/nature07761
   PubMed Web of Science ®Google Scholar
• Lee MJ, Park SH, Han JH, Hong YK, Hwang S, Lee S, Kim D, Han SY, Kim ES, Cho KS. 2011. The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia. Mol Cells. 31:337–342. doi: 10.1007/s10059-011-0042-6
   PubMed Web of Science ®Google Scholar
• Lee S, Bang SM, Hong YK, Lee JH, Jeong H, Park SH, Liu QF, Lee IS, Cho KS. 2016. The calcineurin inhibitor sarah (nebula) exacerbates Abeta42 phenotypes in a Drosophila model of Alzheimer’s disease. Dis Model Mech. 9:295–306. doi: 10.1242/dmm.018069
   PubMed Web of Science ®Google Scholar
• Lee S, Bang SM, Lee JW, Cho KS. 2014. Evaluation of traditional medicines for neurodegenerative diseases using Drosophila models. Evid Based Complement Alternat Med. eCAM.2014:967462.
   PubMedGoogle Scholar
• Lee S, Wang JW, Yu W, Lu B. 2012. Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated Aβ toxicity in Drosophila. Nat Commun. 3:1312. doi: 10.1038/ncomms2278
   PubMed Web of Science ®Google Scholar
• Lin R, Angelin A, Da Settimo F, Martini C, Taliani S, Zhu S, Wallace DC. 2014. Genetic analysis of dTSPO, an outer mitochondrial membrane protein, reveals its functions in apoptosis, longevity, and Aβ42-induced neurodegeneration. Aging Cell. 13:507–518. doi: 10.1111/acel.12200
   PubMed Web of Science ®Google Scholar
• Ling D, Salvaterra PM. 2011. Brain aging and Aβ1–42 neurotoxicity converge via deterioration in autophagy–lysosomal system: a conditional Drosophila model linking Alzheimer’s neurodegeneration with aging. Acta Neuropathol. 121:183–191. doi: 10.1007/s00401-010-0772-0
   PubMed Web of Science ®Google Scholar
• Ling D, Song H-J, Garza D, Neufeld TP, Salvaterra PM. 2009. Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS One. 4:e4201. doi: 10.1371/journal.pone.0004201
   PubMed Web of Science ®Google Scholar
• Liu QF, Jeong H, Lee JH, Hong YK, Oh Y, Kim YM, Suh YS, Bang S, Yun HS, Lee K, et al. 2016. Coriandrum sativum suppresses Aβ42-induced ROS increases, glial cell proliferation, and ERK activation. Am J Chin Med. 44:1325–1347. doi: 10.1142/S0192415X16500749
   PubMed Web of Science ®Google Scholar
• Liu QF, Lee JH, Kim Y-M, Lee S, Hong YK, Hwang S, Oh Y, Lee K, Yun HS, Lee IS, et al. 2015. In vivo screening of traditional medicinal plants for neuroprotective activity against Aβ42 cytotoxicity by using Drosophila models of Alzheimer’s disease. Biol Pharm Bull. 38:1891–1901. doi: 10.1248/bpb.b15-00459
   PubMed Web of Science ®Google Scholar
• Lüchtenborg AM, Katanaev VL. 2014. Lack of evidence of the interaction of the Aβ peptide with the Wnt signaling cascade in Drosophila models of Alzheimer’s disease. Mol Brain. 7:81.
   PubMed Web of Science ®Google Scholar
• Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J. 1999. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am J Pathol. 155:853–862. doi: 10.1016/S0002-9440(10)65184-X
   PubMed Web of Science ®Google Scholar
• Maccioni RB, Farias G, Morales I, Navarrete L. 2010. The revitalized tau hypothesis on Alzheimer’s disease. Arch Med Res. 41:226–231. doi: 10.1016/j.arcmed.2010.03.007
   PubMed Web of Science ®Google Scholar
• Markesbery WR. 1997. Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med. 23:134–147. doi: 10.1016/S0891-5849(96)00629-6
   PubMed Web of Science ®Google Scholar
• Mattson MP. 2004. Pathways towards and away from Alzheimer’s disease. Nature. 430:631–639. doi: 10.1038/nature02621
   PubMed Web of Science ®Google Scholar
• Ollmann M, Young LM, Di Como CJ, Karim F, Belvin M, Robertson S, Whittaker K, Demsky M, Fisher WW, Buchman A, et al. 2000. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell. 101:91–101. doi: 10.1016/S0092-8674(00)80626-1
   PubMed Web of Science ®Google Scholar
• Park SH, Lee S, Hong YK, Hwang S, Lee JH, Bang SM, Kim YK, Koo BS, Lee IS, Cho KS. 2013. Suppressive effects of SuHeXiang Wan on amyloid-β42-induced extracellular signal-regulated kinase hyperactivation and glial cell proliferation in a transgenic Drosophila model of Alzheimer’s disease. Biol Pharm Bull. 36:390–398. doi: 10.1248/bpb.b12-00792
   PubMed Web of Science ®Google Scholar
• Sanokawa-Akakura R, Cao W, Allan K, Patel K, Ganesh A, Heiman G, Burke R, Kemp FW, Bogden JD, Camakaris J, et al. 2010. Control of Alzheimer’s amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila. PLoS One. 5:e8626. doi: 10.1371/journal.pone.0008626
   PubMed Web of Science ®Google Scholar
• Singh C, Mahoney M. 2011. UAS-APP and APP-based constructs and insertions from Vitruvean. Flybase. Personal communication to Flybase:FBrf0213105.
   Google Scholar
• Wang L, Chiang HC, Wu W, Liang B, Xie Z, Yao X, Ma W, Du S, Zhong Y. 2012. Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss. Proc Natl Acad Sci U S A. 109:16743–16748. doi: 10.1073/pnas.1208011109
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Hirano A. 1986. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer’s neurofibrillary tangles. Neuropathol Appl Neurobiol. 12:3–9. doi: 10.1111/j.1365-2990.1986.tb00677.x
   PubMed Web of Science ®Google Scholar